Astal Laboratories board to consider Q4FY26 and FY26 results on May 30
Astal Laboratories Limited will hold a board meeting on May 30, 2026, to consider the audited standalone and consolidated financial results for Q4FY26 and FY26. The board will also review the audited financial statements for the year ended March 31, 2026 and appoint an internal auditor for FY27. The trading window for designated persons remains closed until 48 hours after the meeting.

*this image is generated using AI for illustrative purposes only.
Astal Laboratories Limited has scheduled a board meeting on May 30, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The meeting will be held at the company's corporate office in Telangana to review the financial performance for Q4FY26 and the full fiscal year FY26.
The board will deliberate on the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, along with the report of the auditors. Additionally, the directors will consider the appointment of an internal auditor for the financial year 2026-27.
The trading window for designated persons and their immediate relatives has been closed since April 01, 2026, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015. This window will remain closed until forty-eight hours after the conclusion of the board meeting.
The meeting agenda includes the consideration of the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, accompanied by the limited review report of the auditors. Any other matter with the permission of the chair may also be taken up during the meeting.
Key Meeting Details
| Agenda Item | Description |
|---|---|
| Financial Results | Audited standalone and consolidated results for Q4FY26 and FY26 |
| Financial Statements | Audited standalone and consolidated statements for FY26 |
| Internal Auditor | Appointment for FY27 |
| Trading Window | Closed from April 01, 2026 until 48 hours post-meeting |
Historical Stock Returns for Astal Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.72% | -4.61% | +16.61% | -13.08% | -10.17% | +741.60% |
How will the FY26 financial performance influence Astal Laboratories' capital allocation strategy for the upcoming fiscal year?
What strategic shifts or growth initiatives is the company likely to prioritize based on the full-year audited results?
Could the appointment of a new internal auditor signal a shift in the company's risk management or compliance framework?


































